Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial
- 20 June 2008
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 371 (9629) , 2019-2025
- https://doi.org/10.1016/s0140-6736(08)60839-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchExpert Review of Vaccines, 2007
- Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum CorneumInfection and Immunity, 2007
- Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): Protective efficacy in a double-blind, placebo-controlled challenge studyVaccine, 2007
- Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and MexicoVaccine, 2007
- Vaccination against Enterotoxigenic Escherichia coli, a Cause of Travelers- DiarrheaJournal of Travel Medicine, 2006
- Enterotoxigenic Escherichia coli as Cause of Diarrhea among Mexican Adults and US Travelers in MexicoJournal of Travel Medicine, 2006
- Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groupsVaccine, 2006
- Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal studyThe Lancet, 2003
- Epidemiology of Travelers' Diarrhea and Relative Importance of Various PathogensClinical Infectious Diseases, 1990
- DIARRHEA OF TRAVELERS TO MEXICOAmerican Journal of Epidemiology, 1977